Lumos Pharma, Inc. Profile Avatar - Palmy Investing

Lumos Pharma, Inc.

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phas…

Biotechnology
US, Austin [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of LUMO's Analysis
CIK: 1126234 CUSIP: 55028X109 ISIN: US55028X1090 LEI: - UEI: -
Secondary Listings
LUMO has no secondary listings inside our databases.